Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OLMAthis companyOlema Pharmaceuticals, Inc.	$7.22	-13.37×	4.55×	0×	-13.14×	-93.1%	0.0%	0.0%	0.0%	-33.9%	-37.0%	-6.7%	0×	0.29×	0×	9.95×	0.0%	2	4.21	2	C+
PBYIPuma Biotechnology, Inc.	$8.12	9.6×	2.28×	1.3×	5.56×	61.0%	74.5%	16.3%	13.6%	23.9%	20.4%	14.0%	0.22×	-0.02×	5.63×	2×	0.0%	7	-1.09	4	A
Peer median	—	9.6×	2.28×	1.3×	5.56×	61.0%	74.5%	16.3%	13.6%	23.9%	20.4%	14.0%	0.22×	-0.02×	5.63×	2×	0.0%	7	-1.09	4	—